Ausgabe 1/2019
Inhalt (12 Artikel)
Value Assessment Frameworks in the United States: A Call for Patient Engagement
- Open Access
- Editorial
Vakaramoko Diaby, Askal A. Ali, Alberto J. Montero
Conducting a Time Trade-Off Study Alongside a Clinical Trial: A Case Study and Recommendations
- Open Access
- Practical Application
Jing Shen, Sarah Hill, David Mott, Matthew Breckons, Luke Vale, Rob Pickard
Systematic Review of Economic Models Used to Compare Techniques for Detecting Peripheral Arterial Disease
- Open Access
- Systematic Review
Eoin Moloney, Joanne O’Connor, Dawn Craig, Shannon Robalino, Alexandros Chrysos, Mehdi Javanbakht, Andrew Sims, Gerard Stansby, Scott Wilkes, John Allen
Accommodation and Health Costs of Deinstitutionalized People with Mental Illness Living in Residential Services in Brazil
- Open Access
- Original Research Article
Denise Razzouk
Can We Accurately Predict Cost Effectiveness Without Access to Overall Survival Data? The Case Study of Nivolumab in Combination with Ipilimumab for the Treatment of Patients with Advanced Melanoma in England
- Open Access
- Original Research Article
D. Lee, A. Amadi, J. Sabater, J. Ellis, H. Johnson, S. Kotapati, S. McNamara, A. Walker, M. Cooper, K. Patterson, N. Roskell, Y. Meng
Reduction of Direct Health Costs Associated with Pertussis Vaccination with Acellular Vaccines in Children Aged 0–9 Years with Pertussis in Catalonia (Spain)
- Open Access
- Original Research Article
Pedro Plans-Rubió, Encarna Navas, Pere Godoy, Gloria Carmona, Angela Domínguez, Mireia Jané, Carmen Muñoz-Almagro, Pedro Brotons
Assessing the Impact of Growth Hormone Deficiency (GHD) in Adults: Interpreting Change of the Treatment-Related Impact Measure—Adult Growth Hormone Deficiency (TRIM-AGHD)
- Open Access
- Original Research Article
Meryl Brod, Jane F. Beck, Lise Højbjerre, Donald M. Bushnell, Johan Erpur Adalsteinsson, Lars Wilkinson, Michael Højby Rasmussen
Influence of Idiopathic Pulmonary Fibrosis Progression on Healthcare Resource Use
- Open Access
- Original Research Article
Alex Diamantopoulos, Toby M. Maher, Nils Schoof, Dirk Esser, Corinne LeReun
Cost Effectiveness of Long-Term Incobotulinumtoxin-A Treatment in the Management of Post-stroke Spasticity of the Upper Limb from the Australian Payer Perspective
- Open Access
- Original Research Article
Koji Makino, Dominic Tilden, Carmel Guarnieri, Mia Mudge, Ian J. Baguley
International HTA Experience with Targeted Therapy Approvals for Lung Cancer
- Open Access
- Original Research Article
Fatma Maraiki, J. Byrnes, H. Tuffaha, M. Hinder
Evaluation of the Impact of an Institution-Specific Dofetilide Initiation Protocol on Mean Hospital Length of Stay and Cost for Dofetilide Initiation
- Open Access
- Original Research Article
Steven P. Kennedy, Hanna Iaizzo, Evgueni Fayn, Dalip Singh
Correction to: Can We Accurately Predict Cost Effectiveness Without Access to Overall Survival Data? The Case Study of Nivolumab in Combination with Ipilimumab for the Treatment of Patients with Advanced Melanoma in England
- Open Access
- Correction
D. Lee, A. Amadi, J. Sabater, J. Ellis, H. Johnson, S. Kotapati, S. McNamara, A. Walker, M. Cooper, K. Patterson, N. Roskell, Y. Meng
